Synthetic Biology Governance Accountability

Introduction

Synthetic Biology Governance Accountability refers to the legal and institutional responsibility of scientists, biotechnology companies, research institutions and government authorities for the safe and ethical development and use of synthetic biological technologies.

Synthetic biology involves designing, modifying or constructing biological organisms, genetic materials and cellular systems for specific purposes. Its applications include vaccine development, genetic engineering, agricultural improvement, disease treatment and industrial biotechnology.

However, these technologies may create risks such as accidental release of engineered organisms, genetic contamination, environmental damage, misuse of biological research and threats to public health. Governance accountability ensures that organisations conducting such activities follow legal requirements, disclose relevant risks and accept responsibility for harm caused by negligence or unlawful conduct.

India does not recognise Synthetic Biology Governance Accountability as a separate statutory doctrine. Its principles arise from existing environmental, biotechnology, constitutional and liability laws.

Legal and Regulatory Framework in India

1. Environment (Protection) Act, 1986: Sections 3, 6 and 8 empower the Central Government to take environmental protection measures and regulate hazardous substances. Section 15 provides penalties for contraventions of the Act and applicable rules.

2. Biosafety Rules, 1989: These Rules regulate the manufacture, use, import, export and storage of hazardous microorganisms and genetically engineered organisms or cells. They establish regulatory safeguards for relevant research and commercial activities.

ibkp.dbt.gov.in+1

3. Institutional Biosafety Committees (IBSCs): IBSCs supervise relevant research, review biosafety arrangements and monitor compliance with applicable institutional safety requirements. They also have responsibilities concerning incident reporting and emergency preparedness.

ibkp.dbt.gov.in+1

4. RCGM and GEAC: The Review Committee on Genetic Manipulation (RCGM), functioning under the Department of Biotechnology, monitors safety aspects of relevant research. The Genetic Engineering Appraisal Committee (GEAC) performs regulatory appraisal and approval functions under the 1989 Rules.

dbtindia.gov.in+1

5. Regulations and Guidelines for Recombinant DNA Research and Biocontainment, 2017: These guidelines provide procedures for safe research, biological containment and management of risks associated with relevant biotechnology activities.

Important Case Laws

1. Vellore Citizens’ Welfare Forum v. Union of India (1996) 5 SCC 647

The Supreme Court recognised the precautionary principle and polluter-pays principle as essential elements of Indian environmental law. These principles require preventive action against serious environmental risks and make responsible polluters bear the cost of environmental restoration.

Sci API

2. M.C. Mehta v. Union of India (1987) 1 SCC 395

In the Oleum Gas Leak case, the Supreme Court established the principle of absolute liability for enterprises engaged in hazardous or inherently dangerous activities. This principle is relevant by analogy when biotechnology industries cause harm through hazardous operations or accidental biological releases.

3. Indian Council for Enviro-Legal Action v. Union of India (1996) 3 SCC 212

The Court held that industries responsible for environmental pollution must bear the cost of remedial measures. This judgment supports corporate accountability for environmental damage caused by unsafe biotechnology activities.

4. Gene Campaign v. Union of India, 2024 INSC 545

The Supreme Court delivered a split verdict concerning environmental approval for genetically modified mustard. The judgments discussed biosafety assessment, regulatory transparency, scientific evidence and environmental protection. The case demonstrates the importance of accountability in decisions involving genetic technologies.

India+1

Major Principles of Governance Accountability

Research accountability: Scientists must follow applicable ethical and biosafety standards.

Corporate responsibility: Biotechnology companies must maintain safety procedures and disclose relevant risks.

Regulatory accountability: Authorities must make lawful, transparent and scientifically reasoned decisions.

Environmental responsibility: Organisations must prevent accidental release and ecological damage.

Public participation: Communities should receive relevant information about potentially harmful projects.

Compensation and remediation: Responsible parties should bear appropriate legal and financial consequences for damage caused.

Conclusion

Synthetic Biology Governance Accountability is an emerging legal approach that seeks to ensure responsible scientific research and commercial biotechnology activities. Although India has no separate legislation recognising this doctrine, the Environment (Protection) Act, 1986, Biosafety Rules, 1989 and judicial principles provide its legal foundation. Future regulatory reforms should strengthen independent risk assessment, institutional monitoring, public transparency, incident reporting and liability mechanisms. The objective is to promote biotechnology innovation while protecting human health, environmental safety and public interest.

Note: The cited judgments establish general environmental and regulatory accountability principles. None directly recognises or decides a separate Synthetic Biology Governance Accountability Doctrine.